United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

Competition authorities in Europe have for years grown increasingly concerned about so-called "killer acquisitions," particularly in life sciences where targets often have high innovation potential but little or no turnover.

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

Founded in 2013, Citrine Informatics has grown into one of the leading players in materials informatics, helping companies harness AI and data science to accelerate the design, discovery, and optimization...

United Kingdom Technology

KL

Keltie LLP

A Milestone For Precision Breeding But Will The UK-EU Reset Pause Progress?

This article provides an update to two earlier pieces I wrote in 2021 on UK and EU reforms to the regulation of gene-edited organisms: Reform of Regulation of Gene-Edited Organisms – An update...

European Union Healthcare

M

Murgitroyd

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace seemed unlikely.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

United Kingdom Technology

BJ

Browne Jacobson

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Simpler And More Streamlined Sustainability Disclosure For UK Private Fund Managers: Taking Stock And Comparing With The EU

United Kingdom Finance

GP

Goodwin Procter LLP

Fentanyl Tariffs

Worldwide International

KL

Herbert Smith Freehills Kramer LLP

Future Network Strategy For CO₂ Transport And Storage

United Kingdom Environment

KL

Herbert Smith Freehills Kramer LLP

UK Immigration Salary List 2025

United Kingdom Immigration

RC

Richmond Chambers Immigration Barristers

The Tokenised Future: Unlocking Real-World Assets On The Blockchain

United Kingdom Technology

BL

Barnes Law

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

Keltie is rated as ‘Outstanding' in the 2025 WIPR UK Patents Rankings. This ranking recognises the top firms in UK patent law for their expertise, reputation and client service.

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

A key platform of the government's Life Sciences Sector Plan and the 10-Year Health Plan is for the UK to be a global leader in life sciences.

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna's European Patent No. 3,590,949 ("EP'949") in a dispute with Pfizer and BioNTech.

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

Earlier this year, the European Commission launched a Biotech and Biomanufacturing Hub that provides tools and resources to help companies, particularly start-ups and SMEs...

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

United Kingdom Healthcare

AP

Arnold & Porter

EU Regulatory Reform For Medicinal Products: Bolar Exemption

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

United Kingdom Technology

IG

IR Global

Product Regulation And Metrology Bill Receives Royal Assent

United Kingdom Healthcare

JD

Jones Day

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

United Kingdom Healthcare

AP

Arnold & Porter

Hot Topics: Life Sciences

This update focuses on: the European Commission's new strategy for life sciences; the latest on tariffs on pharmaceutical imports; Microsoft introduces it's new AI diagnostic tool...

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

This digest covers key virtual and digital health regulatory and public policy developments during June and early July 2025 from the United Kingdom and European Union.

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

In the UK's Industrial Strategy, life sciences is one of eight high-growth sectors (the IS-8) with the potential to drive economic growth – while also supporting economic security and resilience...

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

The UK Government has recently published plans for the Life Sciences Sector and the NHS in England. In this blog post, we summarise these plans and some of the initial feedback that has been published by ABPI.

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

United Kingdom Healthcare

LS

Lewis Silkin

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

Globally, market volatility has eroded confidence and subdued M&A activity. A "wait and see" approach is the prevailing sentiment for many market participants...

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

In the latest of our articles about the UK government's industrial strategy and sector plans, we're now taking a look at its tech and digital sector plan.

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

The launch of the Cali Fund at COP16 marked a new international framework for sharing benefits from Digital Sequence Information (DSI).

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

Why the chief executive of Cancer Research UK believes that investment in research, new innovative treatments and diagnostic tools could fulfil the promise of beating the disease.

United Kingdom Healthcare

WL

Withers LLP

Supporting Growth – What Does The UK's Industrial Strategy Mean For Life Sciences?

United Kingdom Healthcare

GW

Gowling WLG

UK Government Issues New Industrial Strategy

United Kingdom Strategy

LS

Lewis Silkin

EU Medical Device Software: New Guidance On Placing Software Medical Devices On The EU Market

European Union Healthcare

AP

Arnold & Porter

Personalised Medicine And MedTech

United Kingdom Healthcare

LS

Lewis Silkin

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

United Kingdom Strategy

IG

IR Global

The Effect Of The Unified Patent Court (UPC) On Opposition Proceedings At The European Patent Office (EPO)

United Kingdom IP

KL

Keltie LLP

Global Insights: Patent Protection For Polymorphs

B

Boult Wade Tennant

Recent Updates On Reform Of UK Clinical Trial Landscape

United Kingdom Healthcare

AP

Arnold & Porter

Blueprints For Growth: Perspectives On Life Sciences & Innovation Investments

United Kingdom Real Estate

AG

Addleshaw Goddard

Future R&D Funding In The UK

United Kingdom Healthcare

MC

Marks & Clerk

Going Down The Bio-Produced Silk Road

United Kingdom IP

MC

Marks & Clerk

A New Approach To Regulation By The MHRA And NICE

United Kingdom Healthcare

AO

A&O Shearman

See more

Latest Videos

See more

Latest Trends With EMA And MHRA Inspections In The EU And UK

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

The International Advantage Of Using A UK Patent Attorney - Dehns And ConceptoMed

D

Dehns

Deloitte Global TMT Predictions 2018 Machine Learning (Video)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More